GO
Loading...

FDA & Avastin's Future

Tuesday, 28 Jun 2011 | 11:15 AM ET

The fate of the world's best-selling cancer medicine is in the hands of the FDA. There's a lot at stake for Roche and the thousands of women who take the drug, reports CNBC's Hampton Pearson.